NMNH: Pure & Third-Party Tested

Mega Resveratrol's Super NMNH is 99% pure pharmaceutical-grade NMNH. Purity is certified by an independent US laboratory, and Certificates of Analysis are publicly available on the website. The formula is also excipient-free, containing no fillers, binders, rice flour, additives, or preservatives.

NMNH supports NAD+ production, which plays a key role in cellular energy metabolism, DNA repair, healthy aging, sirtuin activation, brain health, and reduction of chronic inflammation. As NAD+ levels naturally decline with age, NMNH supplementation helps replenish these levels to support overall vitality and longevity.

The recommended serving is 1 to 2 capsules of 300 mg NMNH daily. Taking 1 capsule per day provides a 90-day supply per bottle. For a comprehensive NAD+ boost, stacking one NMNH capsule with one NMN capsule daily is recommended to cover NAD+ synthesis across different cell types.

Yes. Mega Resveratrol's NMNH is stored at -20°C (-4°F) prior to shipping using cold-chain quality control to preserve maximum potency. After receiving your order, refrigeration is recommended to maintain product stability and effectiveness throughout your supply.

Yes. Mega Resveratrol's NMNH is 100% vegetarian, gluten-free, and non-GMO. The formula is also excipient-free with no fillers or preservatives, making it suitable for a wide range of dietary needs and lifestyles.

Mega Resveratrol operates from a GMP Certified and FDA Registered Facility. Every batch of NMNH undergoes independent third-party lab testing with publicly available Certificates of Analysis, and Mega Resveratrol pioneered voluntary third-party testing in the supplement industry to ensure complete transparency and quality assurance.

Mega Resveratrol's NMNH is trusted by 100+ universities and research institutes worldwide for NAD+ biology and cellular aging studies, with over 50 published studies referencing their products since 2007. It is also used by healthcare providers, compounding pharmacies, and health-conscious consumers seeking pharmaceutical-grade NAD+ support.